Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_953_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Dedication
- •Contributors
- •Foreword
- •Preface
- •Contents
- •Indications/Contraindications
- •Surgery
- •Conclusions
- •Complications
- •Results
- •Indications/Contraindications
- •Surgery
- •Technique
- •Complications
- •Results
- •Conclusions
- •Indications
- •Contraindications
- •Conclusions
- •Surgery
- •Complications
- •Results
- •Conclusions
- •Indications/Contraindications
- •Surgery
- •Complications
- •Results
- •Conclusions
- •Introduction
- •Indications/Contraindications
- •Surgery
- •Complications
- •Results
- •Conclusions
- •Acknowledgments
- •Indications/Contraindications
- •Surgery
- •Complications
- •Results
- •Conclusions
- •Indications/Contraindications
- •Surgery
- •Complications
- •Results
- •Conclusions
- •Indications/Contraindications
- •Surgery
- •Complications
- •Results
- •Conclusions
- •Indications/Contraindications
- •Surgery
- •Complications
- •Results
- •Conclusions
- •Indications/Contraindications
- •Surgery
- •Complications
- •Results
- •Conclusions
- •Introduction
- •Indications
- •Contraindications
- •Results
- •Indications/Contraindications
- •Surgery
- •Complications
- •Results
- •Conclusions
- •Introduction
- •Complications
- •Conclusions
- •Indications/Contraindications
- •Surgery
- •Complications
- •Results
- •Conclusions
- •Indications/Contraindications
- •Surgery
- •Complications
- •Results
- •Conclusions
- •Indications/Contraindications
- •Surgery
- •Complications
- •Results
- •Conclusions
- •Introduction
- •Indications/Contraindications
- •Surgery
- •Complications
- •Results
- •Conclusions
- •Acknowledgments
- •Introduction
- •Indications/Contraindications
- •Surgery
- •Conclusions
- •Complications
- •Results
- •Surgery
- •Complications
- •Results
- •Conclusions
- •Indications/Contraindications
- •Surgery
- •Complications
- •Conclusions
- •Introduction
- •Indications/Contraindications
- •Surgery
- •Complications
- •Results
- •Conclusions
- •Indications/Contraindications
- •Anatomy
- •Complications
- •Results
- •Conclusions
- •Indications/Contraindications
- •Surgery
- •Complications
- •Results
- •Conclusions
- •Introduction
- •Indications/Contraindications

suchasretentionandhydronephrosishavebeenreportedwith
uninterruptedstimulation.
Patientscanincreaseordecreasetheintensityofstimulationinapreset
range.Thisvariationisusuallydonetoensurethatthedeviceisworking
(asanadaptationtotheperceptionofstimulationcanbeobserved),and
toadaptstimulationtovariationsinbodypositioning,suchasdecreased
intensityduringnighttimeinasleepingposition,andtoadjustto
insufficientclinicaleffectiveness.
SNStherapyrequiresmaintenance.Arelevantportionofpatientswill
requirereadjustmentofthestimulationparameterstoensureconstant
optimaltherapeuticeffectivenessduringfollow-up.
FIGURE17-10Systemcomponents
(CourtesyofMedtronic,Inc.)

COMPLICATIONS
BatterylifeoftheINSislimited;batterysize,currentamplitude,and
stimulationusagemainlydeterminelifespan,rangingfrom4to7years.
Acycledprogram(alternatingonandoffforasetduration)orswitching
offthegeneratoratregularintervals(suchasduringsleep)helpsprolong
it.AsthecurrentversionsoftheINSdonotincluderechargeable
batteries,theINSneedstobeexchangedinaminorsurgicalintervention
oncethebatteryisdrained.
TheINSandtheelectrodesaresensitivetomagneticfieldsandthe
manufacturerrecommendsitsremovalifanMRIisneeded.Thecurrent
generationofstimulationsystemsisonlyclassifiedasconditionallysafe
for1.5TheadcoilMRI.
Thedeviceisalsosensitivetounipolarcautery,andhencebipolar
cauteryisadvisedforsurgicalinterventions.
ThemostfrequentcomplicationsassociatedwithchronicSNSareloss
(orlack:inabilitytoreproducethetherapeuticeffectachievedduring
PNE)ofefficacyinanestimated12%,painin13%,infectionin4%,and
adversestimulationeffects.
Ingeneral,onemustestablishwhetherthecomplicationisaresultofthe
treatment—eithermechanicalorfunctional.Thelatterproblemcanoften
becorrectedbyreprogramming.Evenifaslightdislodgementofthe
electrodeisinvolved,thearrangementofthecontactsatthetipofthe
electrodesallowsstimulationfieldsofvarioussizesandshapesthatmay
compensateforaminordislodgement.Thereprogrammingshould
alwaysbedoneinastructuredmanner.Thealgorithmofreprogramming
isthesameifadverseoruncomfortablestimulationeffectsoccur.
Ifelectrodemigrationhasoccurredandreprogrammingisineffective,
revisionalsurgerywithrepositioningisunavoidable.Ifpotentiallossof
efficacyduetoother(notmechanical)causesissuspected,
reimplantationofanewelectrodetoastimulation-naivesacralspinal
nerveisadvised.
Painduringtherapycanalsoresultsimplyfromthepresenceofthe
deviceorfromstimulation.Toexcludepainsecondarytostimulation,
theINSshouldbeswitchedoffforaperiodoftimetoclarifywhetherthe
painiscausedbythecurrent.
Lateinfectionsarefortunatelyrareandareusuallyapparentfrom
clinicalsignssuchasredness,warmth,anddischarge.Ifnotresolved

withadequateantibiotictherapy(coveringStaphylococcusaureus),
removalofthedevice—mostcommonlythecompletedevice—is
unavoidable.Oncetheinfectionhasbeenovercome,reimplantationofa
newsystemcanbeconsidered.
Ingeneral,seriouscomplicationsrequiringdeviceremovalarerare
(<5%),mostlypromptedbyinfectionordevicemalfunction.

RESULTS
Sinceitsfirstuseintreatingfecalincontinence,theclinicalefficacyof
SNShasbeenconfirmedwithreproducibleresultsinmultiplestudies.
Thesestudiesvaryregardingoutcomecriteria,buttypicallyeitherthe
frequencyofinvoluntarylossofbowelcontentortheCCF-FISisused.
Themajorityofstudiesreportasignificantimprovementinsymptoms,
short-andmid-term,regardlessoftheoutcomemeasure(Table17-1).
Withsymptomimprovement,qualityoflifealsoimproves.Thereis
increasingevidencethattheeffectofSNSremainsstable:asustained
clinicalbenefithasbeendemonstratedforupto20years.
TABLE17-1
Mid-andLong-termResultsofSNSforFecalIncontinence(PerProtocolAnalysis)
Incontinenceepisodes/
weekmedian(range)
Author Year
Patients(n)
(follow-up)
Median
follow-up Baseline
Last
follow-up
Medianscore
baseline(range)
FOLLOW-UP12–36MO
Uludag 2004 50 24
*
8(n.a.) 1(n.a.)
Melenhorst 2007 100 36
*
10(n.c.) 2(n.c.)
Dudding 2008 51 24 6(0–81) 1(0–59)
Brouwer 2010 55 36
*
n.a. n.a. 15(13–18)
Michelsen 2010 126 24 n.a. n.a. 16(6–20)
Gallas 2011 200 24
*
n.a. n.a. 14(2–20)
Hollingshead 2011 86 33 9(7)
†
1(2)
†
Mellgren 2011 120 36
*
9(n.a.)
†
2(n.a.)
†
Wong 2011 61 31 n.a. n.a. 14(n.a.)
FOLLOW-UP>36MO
Melenhorst 2007 100 48
*
60
*
10(n.a.)
†
10(n.a.)
†
2(n.c.)
†
2(n.c.)
†
Altomare 2009 60 74
†
4(n.a.)
†
1(n.c.)
†

Brouwer 2010 55 48
*
n.a. n.a. 15(13–18)
Faucheron 2010 87 45 n.a. n.a. 13(6–19)
Michelsen 2010 126 72
*
n.a. n.a. 20(12–20)
Uludag 2011 50 60 8(n.a.) n.a.
Lim 2011 53 51
†
n.a. n.a. 12(9–15)
Duelund-Jakobsen 2012 147 46 6(n.c.) 1(n.c.)
Faucheron 2012 57 63 n.a. n.a. 14(4–19)
Damon 2013 119 48
†
n.a. n.a.
Mellgren 2013 120 >60 9(n.a.) 2(n.a.)
Maeda 2014 108 60
*
n.a. n.a. 16(6–20)
Altomare 2015 272 84 7(4–11) 0.3(0–3) 16(13–18)
Mellgren 2011 120 36 9.4 1.7
*
FISI39.9
Hull 2013 76 60 9.1 1.7 FISI37.95
*
Valuesatspecifictime.
†
Meanvalue,standarddeviation.
FISI,fecalincontinenceseverityindex;n.a.,datanotavailable;n.c.,notcalculable.
ModifiedfromO’ConnellandKnowles,2017.
Patientselectionforpermanentstimulationisuniform,directedbythe
outcomeofthetemporaryteststimulation,whichishighlypredictive.
TherangeofindicationsforSNSinfecalincontinencehassteadily
evolved.Earlyapplicationwasconfinedtoadistinctgroupofpatients
presentingwithweak,butmorphologicallyintact,analsphincteric,and
pelvicfloormusculature.Basedonthehighlypredictivevalueofa
positiveresulttotrialstimulation,whichcarriesminimalrisk,andthe
increasingknowledgethattheeffectofSNSisnotlimitedtothemuscle,
butinvolvesavarietyofphysiologicalfunctionscontributingto
continence,theuseofPNEwasexpanded.Thisexpansionresultedina
broaderapplicationofpermanentSNS,evenforpatientswithstructural
defectsoftheinternalandexternalanalsphincters.Today,SNS
representsanessentialpartofthesurgicalarmamentariumtotreatfecal
incontinence.Italsocarriespotentialforpatientswithconcurrentfecal
andurinaryincontinence.
p.134

p.135
Asystematiccomparisonwithothersurgicaltechniques—basedonthe
existinglevelofevidence—hasledtothecurrentguidelinesofthe
InternationalConsultationofIncontinence.Surgicaltreatmentoffecal
incontinenceisadvisedifconservativemeansdonotresultinadequate
symptomrelief.Iffecalincontinencesecondarytootherunderlying
conditionsisexcluded(suchashigh-gradeinternalrectalprolapse),the
choiceoftreatmentisdirectedbythefindingsofendoanalultrasound.In
thetreatmentalgorithm,SNSiscentral:itisrecommendedinpatients
presentingwithoutasphinctericlesionandasatherapeuticalternativeto
surgicalrepairinthosewithasphinctericgapofupto180degrees.
Althoughtheresultsofthelatterindicationaremorerecent,therecent
findingsareconsistent.

CONCLUSIONS
SNShasevolvedtobecomeanestablishedtreatmentforfecal
incontinence.
Thetherapyisminimallyinvasiveandrelativelylowrisk.
Patientselectionisbasedonatherapeutictrialphase,which—ifclinically
efficient—ishighlypredictiveoftheoutcomeofapermanentstimulation.
TheresultsofSNSarereproducible,andanincreasingbodyofevidence
indicatessustainability.
Thetherapyisreversible.
Thetherapyrequiresmaintenance.

RECOMMENDEDREFERENCESAND
READINGS
AltomareDF,GiuratrabocchettaS,KnowlesCH,MuñozDuyosA,Robert-YapJ,MatzelKE;
EuropeanSNSOutcomeStudyGroup.Long-termoutcomesofsacralnervestimulationfor
faecalincontinence.BrJSurg2015;102:407–15.
HullT,GieseC,WexnerSD,etal;SNSStudyGroup.Long-termdurabilityofsacralnerve
stimulationtherapyforchronicfecalincontinence.DisColonRectum2013;56(2):234–45.
JorgeJM,WexnerSD.Etiologyandmanagementoffecalincontinence.DisColonRectum
1993;36(1):77–97.
MaedaY,LundbyL,BuntzenS,LaurbergS.Suboptimaloutcomefollowingsacralnerve
stimulationforfaecalincontinence.BrJSurg2011;98:140–7.
MaedaY,MatzelK,LundbyL,BuntzenS,LaurbergS.Postoperativeissuesofsacralnerve
stimulationforfaecalincontinenceandconstipation:asystematicliteraturereviewand
treatmentguideline.DisColonRectum2011;54:1443–60.
MatzelKE,KammMA,StösserM,etal.Sacralnervestimulationforfaecalincontinence:a
multicenterstudy.Lancet2004;363:1270–6.
MatzelKE,StadelmaierU,HohenfellnerM,GallFP.Electricalstimulationofsacralspinalnerves
fortreatmentoffaecalincontinence.Lancet1995;346:1124–7.
MelenhorstJ,KochSM,UludagO,vanGemertWG,BaetenCG.Sacralneuromodulationin
patientswithfaecalincontinence:resultsofthefirst100permanentimplantations.Colorectal
Dis2007;9:725–30.
MellgrenA,WexnerSD,CollerJA,etal;SNSStudyGroup.Long-termefficacyandsafetyofsacral
nervestimulationforfecalincontinence.DisColonRectum2011;54(9):1065–75.
O’ConnellR,KnowlesC.Surgeryforfecalincontinence.In:AbramsP,CardozoL,WaggA,Wein
A,eds.Incontinence.6thed.Bristol,UK:InternationalContinenceSociety,2017:2087–142.
TanJJ,ChanM,TjandraJJ.Evolvingtherapyforfaecalincontinence.DisColonRectum
2007;50:1950–6.
WexnerSD,CollerJA,DevroedeG,etal.Sacralnervestimulationforfaecalincontinence:results
ofa120-patientprospectivemulticenterstudy.AnnSurg2010;251:441–9.

PARTV
PERINEALPROLAPSEREPAIR

Chapter18
DelormeProcedure
DeborahS.Keller,HemanM.Joshi,andC.
RichardCohen
INTRODUCTION
Rectalprolapseisadebilitatingconditionthataffectsthepatient’spelvic
flooranatomy,function,andqualityoflife.Rectalprolapseisfrequently
associatedwithprogressivefecalincontinence,constipation,andother
pelvicfloordisorders,suchasmulticompartmentprolapseandurinary
incontinence.Symptomsofrectalprolapseincludethephysicalfeelingof
abulge,mucusdrainage,tenesmus,rectalpainandpressure,andrectal
bleeding.Surgeryistheonlycurativetreatmentforrectalprolapse,anda
varietyofproceduresareavailable.
TheDelormeprocedureisamucosalsleeveresectionperformedviaa
perinealapproachforfull-thicknessexternalrectalprolapse.After
reproducingtheprolapse,themucosaisstrippedfromtheprolapsed
segmentandresected,themusclelayersareplicated,theprolapse
inverted,andthemucosaisreapproximated.
Соседние файлы в папке Библиотека им академика М.И. Перельмана
